Re "in New Zealand and Canada and the approval is for children and adults." Was there a later announcement than this http://www.asx.com.au/asxpdf/20140429/pdf/42p7qg0gyxdn7q.pdf in particular " Prochymal became the world's first stem cell therapy to be approved in Canada and New Zealand as a first-line treatment for SR-aGVHD in children."? Japan is the market that has it approved in both adults and children I believe.
Also, I am not sure of the logic with "Obvious it works other wise they would not have purchased Osiris!" Osiris sold it presumably because they felt they should; it failed to meet end points in NZ and Canada . With regards "Mesoblast has moved on with making changes to there technology."; ok, if they have and it is beneficial I guess we will see in time.
Ann: Change in substantial holding, page-20
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |